Detalles de la búsqueda
1.
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
N Engl J Med;
387(12): 1089-1098, 2022 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36027570
2.
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation;
146(16): 1210-1224, 2022 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36029465
3.
Association between spirometry pattern, left ventricular diastolic function, and mortality.
Eur J Clin Invest;
53(10): e14043, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37340550
4.
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial.
Ann Intern Med;
175(6): 820-830, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35467935
5.
Alirocumab after acute coronary syndrome in patients with a history of heart failure.
Eur Heart J;
43(16): 1554-1565, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34922353
6.
2023 Guidelines of the Taiwan Society of Cardiology on the Diagnosis and Management of Chronic Coronary Syndrome.
Acta Cardiol Sin;
39(1): 4-96, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36685161
7.
2023 Consensus of Taiwan Society of Cardiology on the Pharmacological Treatment of Chronic Heart Failure.
Acta Cardiol Sin;
39(3): 361-390, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37229331
8.
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF.
Circulation;
143(20): 1962-1972, 2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33832352
9.
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med;
381(21): 1995-2008, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31535829
10.
Hospitalization for Heart Failure in the United States, UK, Taiwan, and Japan: An International Comparison of Administrative Health Records on 413,385 Individual Patients.
J Card Fail;
28(3): 353-366, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34634448
11.
The fibrosis-4 score is associated with long-term mortality in different phenotypes of acute heart failure.
Eur J Clin Invest;
52(12): e13856, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35975623
12.
Revisiting 'intensive' blood glucose control: A causal directed acyclic graph-guided systematic review of randomized controlled trials.
Diabetes Obes Metab;
24(12): 2341-2352, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35848464
13.
Optimal stroke preventive strategy for patients aged 80 years or older with atrial fibrillation: a systematic review with traditional and network meta-analysis.
Age Ageing;
51(12)2022 12 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36571776
14.
The Efficacy and Safety of Short-Term Tolvaptan Usage in Patients with Acute Decompensated Heart Failure.
Acta Cardiol Sin;
38(6): 700-713, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36440253
15.
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
Acta Cardiol Sin;
38(3): 225-325, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35673334
16.
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF.
Circulation;
141(2): 100-111, 2020 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31736328
17.
Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan.
Pharmacogenomics J;
21(3): 346-358, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33649520
18.
Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data.
Cardiovasc Diabetol;
20(1): 159, 2021 07 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34332558
19.
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.
Eur Heart J;
41(24): 2248-2258, 2020 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31732742
20.
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF).
Eur Heart J;
41(36): 3402-3418, 2020 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32820334